• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特异性剔除 NCoR 核心抑制因子 δ 剪接变异体揭示了可变剪接作为肝脏代谢关键调控因子的作用。

Specific ablation of the NCoR corepressor δ splice variant reveals alternative RNA splicing as a key regulator of hepatic metabolism.

机构信息

Department of Microbiology and Molecular Genetics, College of Biological Sciences, University of California at Davis, Davis, California, United States of America.

Department of Molecular Biosciences, School of Veterinary Medicine and Mouse Metabolic Phenotyping Center, Microbiome & Host Response Core, University of California at Davis, Davis, California, United States of America.

出版信息

PLoS One. 2020 Oct 26;15(10):e0241238. doi: 10.1371/journal.pone.0241238. eCollection 2020.

DOI:10.1371/journal.pone.0241238
PMID:33104749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7588069/
Abstract

The NCoR corepressor plays critical roles in mediating transcriptional repression by both nuclear receptors and non-receptor transcription factors. Alternative mRNA splicing of NCoR produces a series of variants with differing molecular and biological properties. The NCoRω splice-variant inhibits adipogenesis whereas the NCoRδ splice-variant promotes it, and mice bearing a splice-specific knockout of NCoRω display enhanced hepatic steatosis and overall weight gain on a high fat diet as well as a greatly increased resistance to diet-induced glucose intolerance. We report here that the reciprocal NCoRδ splice-specific knock-out mice display the contrary phenotypes of reduced hepatic steatosis and reduced weight gain relative to the NCoRω-/- mice. The NCoRδ-/- mice also fail to demonstrate the strong resistance to diet-induced glucose intolerance exhibited by the NCoRω-/- animals. The NCoR δ and ω variants possess both unique and shared transcriptional targets, with expression of certain hepatic genes affected in opposite directions in the two mutants, others altered in one but not the other genotype, and yet others changed in parallel in both NCoRδ-/- and NCoRω-/- animals versus WT. Gene set expression analysis (GSEA) identified a series of lipid, carbohydrate, and amino acid metabolic pathways that are likely to contribute to their distinct steatosis and glucose tolerance phenotypes. We conclude that alternative-splicing of the NCoR corepressor plays a key role in the regulation of hepatic energy storage and utilization, with the NCoRδ and NCoRω variants exerting both opposing and shared functions in many aspects of this phenomenon and in the organism as a whole.

摘要

NCoR 核心抑制因子在介导核受体和非受体转录因子的转录抑制中发挥关键作用。NCoR 的选择性剪接产生了一系列具有不同分子和生物学特性的变体。NCoRω 剪接变体抑制脂肪生成,而 NCoRδ 剪接变体促进脂肪生成,并且携带 NCoRω 剪接特异性敲除的小鼠在高脂肪饮食下表现出增强的肝脂肪变性和总体体重增加,以及对饮食诱导的葡萄糖不耐受的极大增强抗性。我们在这里报告,相反的 NCoRδ 剪接特异性敲除小鼠表现出相对于 NCoRω-/-小鼠减少的肝脂肪变性和减少的体重增加的表型。NCoRδ-/-小鼠也未能表现出 NCoRω-/-动物所表现出的对饮食诱导的葡萄糖不耐受的强烈抗性。NCoRδ 和 ω 变体都具有独特和共享的转录靶标,某些肝基因的表达在两种突变体中以相反的方向受到影响,其他基因在一种基因型中改变而在另一种基因型中不改变,而其他基因在 NCoRδ-/-和 NCoRω-/-动物中与 WT 相比以平行方式改变。基因集表达分析(GSEA)鉴定了一系列可能有助于其不同的脂肪变性和葡萄糖耐量表型的脂质、碳水化合物和氨基酸代谢途径。我们得出结论,NCoR 核心抑制因子的选择性剪接在肝脏能量储存和利用的调节中发挥关键作用,NCoRδ 和 NCoRω 变体在这一现象的许多方面以及整个生物体中发挥着相反和共同的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f1/7588069/98839d807987/pone.0241238.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f1/7588069/fdaaf4b783a0/pone.0241238.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f1/7588069/e0227555c303/pone.0241238.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f1/7588069/b66e876d5466/pone.0241238.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f1/7588069/9b1338bdc301/pone.0241238.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f1/7588069/1d886811a4a7/pone.0241238.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f1/7588069/98839d807987/pone.0241238.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f1/7588069/fdaaf4b783a0/pone.0241238.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f1/7588069/e0227555c303/pone.0241238.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f1/7588069/b66e876d5466/pone.0241238.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f1/7588069/9b1338bdc301/pone.0241238.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f1/7588069/1d886811a4a7/pone.0241238.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f1/7588069/98839d807987/pone.0241238.g006.jpg

相似文献

1
Specific ablation of the NCoR corepressor δ splice variant reveals alternative RNA splicing as a key regulator of hepatic metabolism.特异性剔除 NCoR 核心抑制因子 δ 剪接变异体揭示了可变剪接作为肝脏代谢关键调控因子的作用。
PLoS One. 2020 Oct 26;15(10):e0241238. doi: 10.1371/journal.pone.0241238. eCollection 2020.
2
Alteration of NCoR corepressor splicing in mice causes increased body weight and hepatosteatosis without glucose intolerance.小鼠中NCoR共抑制因子剪接的改变导致体重增加和肝脂肪变性,但无葡萄糖不耐受。
Mol Cell Biol. 2014 Nov 15;34(22):4104-14. doi: 10.1128/MCB.00554-14. Epub 2014 Sep 2.
3
Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation.核心抑制物的可变剪接产生了在脂肪细胞分化中发挥相反作用的变异体。
J Biol Chem. 2011 Dec 30;286(52):44988-99. doi: 10.1074/jbc.M111.291625. Epub 2011 Nov 7.
4
Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling.激素和代谢信号对共抑制因子可变mRNA剪接的调控。
Mol Cell Endocrinol. 2015 Sep 15;413:228-35. doi: 10.1016/j.mce.2015.06.036. Epub 2015 Jul 10.
5
Corepressor diversification by alternative mRNA splicing is species specific.通过可变mRNA剪接实现的共抑制因子多样化具有物种特异性。
BMC Evol Biol. 2016 Oct 19;16(1):221. doi: 10.1186/s12862-016-0781-2.
6
Evolution of NCoR-1 and NCoR-2 corepressor alternative mRNA splicing in placental mammals.胎盘哺乳动物中NCoR-1和NCoR-2共抑制因子可变mRNA剪接的进化
BMC Res Notes. 2019 Jun 17;12(1):343. doi: 10.1186/s13104-019-4384-z.
7
Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet.长期摄入极低碳水化合物生酮饮食的小鼠的肝脂肪变性、炎症和内质网应激。
Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G956-67. doi: 10.1152/ajpgi.00539.2010. Epub 2011 Mar 31.
8
Proteoglycan 4 deficiency protects against glucose intolerance and fatty liver disease in diet-induced obese mice.蛋白聚糖 4 缺乏可预防饮食诱导肥胖小鼠的葡萄糖不耐受和脂肪肝疾病。
Biochim Biophys Acta Mol Basis Dis. 2019 Feb 1;1865(2):494-501. doi: 10.1016/j.bbadis.2018.11.009. Epub 2018 Nov 15.
9
The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.过氧化物酶体增殖物激活受体γ的核受体辅阻遏物(NCoR)的最佳辅阻遏物功能需要G蛋白途径抑制因子2。
J Biol Chem. 2015 Feb 6;290(6):3666-79. doi: 10.1074/jbc.M114.598797. Epub 2014 Dec 17.
10
Transcriptional profiling reveals a role for RORalpha in regulating gene expression in obesity-associated inflammation and hepatic steatosis.转录谱分析揭示了 RORalpha 在调节肥胖相关炎症和肝脂肪变性中的基因表达中的作用。
Physiol Genomics. 2011 Jul 14;43(13):818-28. doi: 10.1152/physiolgenomics.00206.2010. Epub 2011 May 3.

引用本文的文献

1
Alternative splicing: hallmark and therapeutic opportunity in metabolic liver disease.可变剪接:代谢性肝病的标志与治疗契机
Gastroenterol Rep (Oxf). 2025 May 26;13:goaf044. doi: 10.1093/gastro/goaf044. eCollection 2025.
2
RNA-seq reveals insights into molecular mechanisms of metabolic restoration via tryptophan supplementation in low birth weight piglet model.RNA-seq 揭示了通过色氨酸补充改善低出生体重仔猪模型代谢恢复的分子机制。
J Anim Sci. 2022 May 1;100(5). doi: 10.1093/jas/skac156.
3
Therapeutic RNA-silencing oligonucleotides in metabolic diseases.

本文引用的文献

1
Transcriptional Control of Circadian Rhythms and Metabolism: A Matter of Time and Space.转录控制生物钟和代谢:时间和空间的问题。
Endocr Rev. 2020 Oct 1;41(5):707-32. doi: 10.1210/endrev/bnaa014.
2
The Nuclear Receptor-Co-repressor Complex in Control of Liver Metabolism and Disease.核受体共抑制因子复合物对肝脏代谢及疾病的调控
Front Endocrinol (Lausanne). 2019 Jun 26;10:411. doi: 10.3389/fendo.2019.00411. eCollection 2019.
3
Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
代谢疾病的治疗性 RNA 沉默寡核苷酸。
Nat Rev Drug Discov. 2022 Jun;21(6):417-439. doi: 10.1038/s41573-022-00407-5. Epub 2022 Feb 24.
突变甲状腺激素受体与核心抑制剂之间的病理性相互作用及其被一种具有治疗潜力的甲状腺激素类似物的调节。
Thyroid. 2018 Dec;28(12):1708-1722. doi: 10.1089/thy.2017.0551. Epub 2018 Oct 16.
4
Nuclear receptors and liver disease: Summary of the 2017 basic research symposium.核受体与肝脏疾病:2017年基础研究研讨会综述
Hepatol Commun. 2018 Jun 14;2(7):765-777. doi: 10.1002/hep4.1203. eCollection 2018 Jul.
5
Divergent Role of Estrogen-Related Receptor α in Lipid- and Fasting-Induced Hepatic Steatosis in Mice.雌激素相关受体α在小鼠脂饥饿诱导的肝脂肪变性中的差异作用。
Endocrinology. 2018 May 1;159(5):2153-2164. doi: 10.1210/en.2018-00115.
6
Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance.营养感应核受体PPARα和FXR控制肝脏能量平衡。
J Clin Invest. 2017 Apr 3;127(4):1193-1201. doi: 10.1172/JCI88893. Epub 2017 Mar 13.
7
Salmon provides fast and bias-aware quantification of transcript expression.鲑鱼提供快速且无偏倚的转录本表达定量。
Nat Methods. 2017 Apr;14(4):417-419. doi: 10.1038/nmeth.4197. Epub 2017 Mar 6.
8
Corepressor diversification by alternative mRNA splicing is species specific.通过可变mRNA剪接实现的共抑制因子多样化具有物种特异性。
BMC Evol Biol. 2016 Oct 19;16(1):221. doi: 10.1186/s12862-016-0781-2.
9
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.肝脏中的过氧化物酶体增殖物激活受体α(PPARα)对于全身脂肪酸稳态至关重要,并且对非酒精性脂肪性肝病具有保护作用。
Gut. 2016 Jul;65(7):1202-14. doi: 10.1136/gutjnl-2015-310798. Epub 2016 Feb 1.
10
Short linear motif acquisition, exon formation and alternative splicing determine a pathway to diversity for NCoR-family co-repressors.短线性基序的获得、外显子形成和可变剪接决定了NCoR家族共抑制因子的多样化途径。
Open Biol. 2015 Aug;5(8). doi: 10.1098/rsob.150063.